Next Article in Journal
Is 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a Clinically Relevant Uremic Toxin in Haemodialysis Patients?
Next Article in Special Issue
Intestinal Barrier Function in Chronic Kidney Disease
Previous Article in Journal
Botulinum Toxin Type A Injection for Cervical Dystonia in Adults with Dyskinetic Cerebral Palsy
Previous Article in Special Issue
The Role of Gut Microbiota and Diet on Uremic Retention Solutes Production in the Context of Chronic Kidney Disease
 
 
Article

Article Versions Notes

Action Date Notes Link
article xml file uploaded 16 May 2018 17:55 CEST Original file -
article pdf uploaded. 16 May 2018 17:55 CEST Version of Record https://www.mdpi.com/2072-6651/10/5/204/pdf-vor
article pdf uploaded. 21 May 2018 02:32 CEST Updated version of record https://www.mdpi.com/2072-6651/10/5/204/pdf
article xml uploaded. 21 May 2018 02:32 CEST Update https://www.mdpi.com/2072-6651/10/5/204/xml
article html file updated 21 May 2018 02:33 CEST Original file -
article html file updated 31 May 2018 12:42 CEST Update -
article html file updated 30 March 2019 01:32 CET Update -
article html file updated 16 April 2019 19:40 CEST Update -
article html file updated 30 April 2019 19:12 CEST Update -
article html file updated 3 October 2019 16:07 CEST Update -
article html file updated 9 February 2020 17:53 CET Update https://www.mdpi.com/2072-6651/10/5/204/html
Back to TopTop